At Rexis (Re-X-Is), our success begins with our proprietary drug delivery platform, Fused Polymorph Nano Fiber Technology™. Our groundbreaking nanotechnology empowers brands to turn the rapidly growing industry of natural, plant-based consumables into products you’ll actually want to taste and drink; something you’ll inevitably crave. From cutting-edge technology to top-notch scientific expertise, we strive to create products that aren’t just better than the rest, but that are better for you. In other words, we make your consumables taste better, your medicine work better and your drugs more fun.
| Website | http://www.rexissystems.com |
| Employees | 6 (6 on RocketReach) |
| Founded | 2022 |
| Address | 1, Las Vegas, Nevada, US |
| Industry | Biotechnology Research |
| Keywords | Biotech, Nanotechnology, Nanomedicine, Drug Delivery, Drug Development, Plant Based, Pharmaceutical, Proprietary Technology, Biomaterials, Natural Products, Delivery Platform, Advanced Materials, Consumables, Scientific Research, Innovative Solutions, Plant Extracts, Research And Development, Health And Wellness |
| Competitors | Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, Labcorp, Fisher Scientific, PerkinElmer, Inc., QIAGEN, GE HealthCare, Merck Group +40 more (view full list) |
Looking for a particular Rexis Biotech employee's phone or email?
Keith Bushfield is the CEO of Rexis Biotech.
6 people are employed at Rexis Biotech.
Rexis Biotech is based in Las Vegas, Nevada.